SEC Form 4 · accession 0001185185-16-005981
IGC Pharma, Inc. · IGC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard K Prins
Director
Period of report
Dec 16, 2016
Accepted (ET)
Dec 20, 2016 · 5:43 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001326205
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock | Apr 4, 2016 | G | 2,000 | $0.00 | D | 315,000 | D | |
| Common stock | Apr 8, 2016 | G | 2,000 | $0.00 | D | 313,000 | D | |
| Common stock | Apr 15, 2016 | G | 2,000 | $0.00 | D | 311,000 | D | |
| Common stock | Apr 22, 2016 | G | 2,000 | $0.00 | D | 309,000 | D | |
| Common stock | Apr 29, 2016 | G | 2,000 | $0.00 | D | 307,000 | D | |
| Common stock | May 6, 2016 | G | 2,000 | $0.00 | D | 305,000 | D | |
| Common stock | May 13, 2016 | G | 2,000 | $0.00 | D | 303,000 | D | |
| Common stock | May 20, 2016 | G | 2,000 | $0.00 | D | 301,000 | D | |
| Common stock | May 27, 2016 | G | 2,000 | $0.00 | D | 299,000 | D | |
| Common stock | Jun 3, 2016 | G | 2,000 | $0.00 | D | 297,000 | D | |
| Common stock | Jun 10, 2016 | G | 2,000 | $0.00 | D | 295,000 | D | |
| Common stock | Jun 17, 2016 | G | 8,000 | $0.00 | D | 287,000 | D | |
| Common stock | Jul 8, 2016 | G | 2,000 | $0.00 | D | 285,000 | D | |
| Common stock | Jul 15, 2016 | G | 2,000 | $0.00 | D | 283,000 | D | |
| Common stock | Jul 22, 2016 | G | 2,000 | $0.00 | D | 281,000 | D | |
| Common stock | Jul 29, 2016 | G | 2,000 | $0.00 | D | 279,000 | D | |
| Common stock | Aug 5, 2016 | G | 2,000 | $0.00 | D | 277,000 | D | |
| Common stock | Aug 12, 2016 | G | 2,000 | $0.00 | D | 275,000 | D | |
| Common stock | Aug 19, 2016 | G | 2,000 | $0.00 | D | 273,000 | D | |
| Common stock | Aug 26, 2016 | G | 2,000 | $0.00 | D | 271,000 | D | |
| Common stock | Sep 2, 2016 | G | 2,000 | $0.00 | D | 269,000 | D | |
| Common stock | Sep 9, 2016 | G | 2,000 | $0.00 | D | 267,000 | D | |
| Common stock | Sep 16, 2016 | G | 2,000 | $0.00 | D | 265,000 | D | |
| Common stock | Sep 23, 2016 | G | 2,000 | $0.00 | D | 263,000 | D | |
| Common stock | Sep 30, 2016 | G | 2,000 | $0.00 | D | 261,000 | D | |
| Common stock | Oct 7, 2016 | G | 2,000 | $0.00 | D | 259,000 | D | |
| Common stock | Oct 14, 2016 | G | 2,000 | $0.00 | D | 257,000 | D | |
| Common stock | Oct 21, 2016 | G | 2,000 | $0.00 | D | 255,000 | D | |
| Common stock | Oct 28, 2016 | G | 2,000 | $0.00 | D | 253,000 | D | |
| Common stock | Nov 4, 2016 | G | 2,000 | $0.00 | D | 251,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Remarks
THIS FORM 4 IS CONTINUED ON THE FORM 4 FILED IMMEDIATELY AFTER THIS FORM 4. THE FILINGS WERE SEPARATED DUE TO INSUFFICIENT ROOM ON THE FIRST FILING TO SUPPLY ALL OF THE DATA.